Skip to main content
Fig. 2 | BMC Chemistry

Fig. 2

From: HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular docking application

Fig. 2

HPLC chromatogram for resolving EMP, LIN, and MET along with MEL and CYG using Zorbax® SB C8 column (4.6 × 250 mm, 5 μm) and an isocratic mobile phase composed of acetonitrile: 0.05 M potassium di-hydrogen phosphate buffer treated with ο-phosphoric acid to get a pH of 4 (90: 10, v/v) with detection at 250 nm employing at a flow rate of 1.2 mL/min

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us